Details for Patent: 6,878,698
✉ Email this page to a colleague
Summary for Patent: 6,878,698
Title: | Anti-inflammatory androstane derivatives |
Abstract: | According to one aspect of the invention, there is provided a pharmaceutical formulation for administration by inhalation comprising a compound of formula (I), ##STR1## wherein R.sub.1 represents C.sub.1-6 alkyl or C.sub.1-6 haloalkyl; R.sub.2 represents --C(.dbd.O)-aryl or --C(.dbd.O)-heteroaryl; R.sub.3 represents hydrogen, methyl (which may be in either the .alpha. or .beta. configuration) or methylene; R.sub.4 and R.sub.5 are the same or different and each represents hydrogen or halogen; and {character pullout} represents a single or a double bond; and salts and solvates thereof together with a long-acting .beta..sub.2 -adrenoreceptor agonist which formulation has a therapeutically useful effect in the treatment of COPD over a period of 24 hours or more. |
Inventor(s): | Biggadike; Keith (Stevenage, GB), Jones; Paul Spencer (Stevenage, GB), Payne; Jeremy John (Stevenage, GB) |
Assignee: | Glaxo Group Limited (Greenford, GB) |
Application Number: | 10/281,735 |
Patent Claim Types: see list of patent claims | Use; Formulation; Composition; Delivery; |
Drugs Protected by US Patent 6,878,698
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,878,698
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 0108800 | Apr 07, 2001 |
International Family Members for US Patent 6,878,698
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
African Regional IP Organization (ARIPO) | 1422 | ⤷ Try a Trial | |||
Argentina | 032361 | ⤷ Try a Trial | |||
Argentina | 032471 | ⤷ Try a Trial | |||
Argentina | 038348 | ⤷ Try a Trial | |||
Argentina | 038686 | ⤷ Try a Trial | |||
Argentina | 063555 | ⤷ Try a Trial | |||
Austria | 342053 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |